Pharmaceutical Technology-Updates The latest content updates from the web site en-us Pharmaceutical Technology-Updates HOFinsight - Innovative Ideas, Innovative Solutions HOFinsight is HOF's customer magazine for innovations and developments. This first issue includes Synchofreeze optimised freeze-drying, HOF's loading and unloading systems, and the R&D Lyo for continuous development. Fri, 28 Jul 2017 14:04:00 GMT HOF to Host Its Second Technical Forum HOF has announced its second technical forum 'Always Think Ahead'. Fri, 28 Jul 2017 13:56:00 GMT ABL&E Announced Exclusive Distributor for Gamlen Instruments in Eastern Europe Gamlen Instruments has appointed ABL&E as the exclusive distributor for Gamlen Instruments in Eastern Europe. Fri, 28 Jul 2017 12:43:00 GMT Bel-Ray-Greases and Lubricants for the Pharmaceutical Industry Bel-Ray specialises in creating lubricants and grease for the pharmaceutical industry. Fri, 28 Jul 2017 10:20:00 GMT Eisai seeks marketing authorisation for lenvatinib from EMA Eisai has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for first-line use of lenvatinib in patients with unresectable hepatocellular carcinoma (uHCC). Thu, 27 Jul 2017 23:00:00 GMT Deals this week: Fidson Healthcare, Sarepta Therapeutics, North China Pharmaceutical Nigerian pharmaceutical company Fidson Healthcare plans to raise NGN6bn ($18.65m) through a rights offering of shares. Thu, 27 Jul 2017 23:00:00 GMT AstraZeneca’s faslodex receives EU approval for advanced breast cancer treatment The European Commission (EC) has approved AstraZeneca’s faslodex (fulvestrant) for the treatment of oestrogen-receptor positive, locally advanced or metastatic breast cancer in postmenopausal women not previously treated with endocrine therapy. Thu, 27 Jul 2017 23:00:00 GMT ViiV reaches another milestone in the development of a long-acting HIV regimen On July 24, 2017, ViiV Healthcare announced positive results from 96-week data obtained from a Phase IIb, open-label study (LATTE-2) investigating the safety and efficacy of a two-drug, long-acting injectable anti-HIV formulation composed of ViiV’s c… Thu, 27 Jul 2017 15:20:00 GMT CAR-T Acknowledged by FDA Committee Novartis has announced its CAR-T cell therapy CTL019 has been recommended by the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC). Thu, 27 Jul 2017 15:20:00 GMT interlanguage-Medical Translation Services for the Pharmaceutical Industry interlanguage provides ISO 17100-certified medical translation services to companies in the worldwide life science sector to improve international communication. Thu, 27 Jul 2017 15:04:00 GMT Micromeritics-Materials Characterisation Analytical Instruments and Services Founded in 1962, Micromeritics is a leading supplier of materials characterization analytical laboratory instrumentation and services. Thu, 27 Jul 2017 15:03:00 GMT Imaging Centre of Excellence, University of Glasgow, Scotland The Imaging Centre of Excellence (ICE) at the Queen Elizabeth University Hospital (QEUH) in Scotland was inaugurated in March 2017. Wed, 26 Jul 2017 23:00:00 GMT Zenith Technologies Seeks New Engineers Worldwide system integration company Zenith Technologies is currently looking to take on new engineers. Wed, 26 Jul 2017 23:00:00 GMT FDA grants fast-track status for Ablynx’s caplacizumab to treat aTTP Belgian biopharmaceutical company Ablynx has received fast-track designation from the US Food and Drug Administration (FDA) for its caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (aTTP). Wed, 26 Jul 2017 23:00:00 GMT Sandoz to improve treatment access to children with cancer in four developing nations Novartis Group division Sandoz has expanded its partnership with UK-based charity World Child Cancer to improve access to treatment, as well as optimise survival outcomes for children suffering from cancer in four developing nations. Wed, 26 Jul 2017 23:00:00 GMT New study discovers faulty genes underlying brain tumours A new in-depth study funded by Cancer Research UK has shown that medulloblastoma brain tumours have faulty genes underlying the disease. Wed, 26 Jul 2017 23:00:00 GMT Dry Powder Inhaler Monodose RS01 Patented, manufactured, and marketed by Plastiape, the RS01 Monodose Dry Powder Inhaler has a refined piercing unit design, which required the study of new manufacturing techniques and a different assembly sequence in comparison with the older device… Wed, 26 Jul 2017 14:57:00 GMT Addressing Serialisation Challenges to Achieve Business Benefits and Best Practice Deployment in the Pharmaceutical Sector With EU and US serialisation deadlines coming closer, companies are realising the benefits of track and trace. Wed, 26 Jul 2017 14:56:00 GMT Atlant Clinical to Become a Gold Sponsor for YJP Life Science & Healthcare Conferences Atlant Clinical has become a sponsor for regular Life Science & Healthcare conferences organised by YJP. Wed, 26 Jul 2017 09:01:00 GMT Dispelling the Myths of Deviation and CAPA Systems 'How to Simplify for Improve your Deviation and CAPA Systems' is one of NSF's most popular in-house courses. The company provides simple tools and techniques that dramatically improve efficiency, while also dispelling some myths. Here is a sample of … Wed, 26 Jul 2017 08:55:00 GMT